XKRX:288330 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
7,700
-200 (-2.5%)
Apr 1
What is a stock summary page? Click here for an overview.
Business Description
Bridge Biotherapeutics Inc
ISIN : KR7288330004
Share Class Description:
XKRX:288330: Ordinary SharesCompare
Compare
Traded in other countries / regions
288330.Korea Index Membership
KOSDAQ Composite Index IPO Date
2019-12-20Description
Bridge Biotherapeutics Inc is a drug research and development company. It operates in the pharmaceutical and bio industry. The company has two pipeline clinical-stage products namely, BBT-401 and BBT-877.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 9.14 | |||||
| Equity-to-Asset | 0.75 | |||||
| Debt-to-Equity | 0.1 | |||||
| Debt-to-EBITDA | -0.1 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 19.66 | |||||
| Beneish M-Score | 157.27 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -75.6 | |||||
| 3-Year EBITDA Growth Rate | -26.1 | |||||
| 3-Year EPS without NRI Growth Rate | -24.3 | |||||
| 3-Year FCF Growth Rate | -31.4 | |||||
| 3-Year Book Growth Rate | -37.1 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.39 | |||||
| 9-Day RSI | 70.02 | |||||
| 14-Day RSI | 70.07 | |||||
| 3-1 Month Momentum % | 28.53 | |||||
| 6-1 Month Momentum % | 23.75 | |||||
| 12-1 Month Momentum % | 29.24 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.56 | |||||
| Quick Ratio | 4.56 | |||||
| Cash Ratio | 4.33 | |||||
| Days Sales Outstanding | 365 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.7 | |||||
| Shareholder Yield % | -6.36 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 22.22 | |||||
| Operating Margin % | -2493215.46 | |||||
| Net Margin % | -2756154.35 | |||||
| FCF Margin % | -2217005.28 | |||||
| ROE % | -139.31 | |||||
| ROA % | -93.19 | |||||
| ROIC % | -173.99 | |||||
| 3-Year ROIIC % | -184.84 | |||||
| ROC (Joel Greenblatt) % | -785.86 | |||||
| ROCE % | -118.15 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 312000 | |||||
| PB Ratio | 13.58 | |||||
| Price-to-Tangible-Book | 17.41 | |||||
| EV-to-EBIT | -11.83 | |||||
| EV-to-EBITDA | -12.44 | |||||
| EV-to-Revenue | 316000.66 | |||||
| EV-to-FCF | -14.64 | |||||
| Price-to-GF-Value | 3436.12 | |||||
| Price-to-Net-Current-Asset-Value | 22.73 | |||||
| Price-to-Net-Cash | 22.32 | |||||
| Earnings Yield (Greenblatt) % | -8.45 | |||||
| FCF Yield % | -6.63 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bridge Biotherapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 1.08 | ||
| EPS (TTM) (â‚©) | -908.976 | ||
| Beta | 1.42 | ||
| 3-Year Sharpe Ratio | 0.16 | ||
| 3-Year Sortino Ratio | 0.26 | ||
| Volatility % | 117.3 | ||
| 14-Day RSI | 70.07 | ||
| 14-Day ATR (â‚©) | 583.159698 | ||
| 20-Day SMA (â‚©) | 6360.5 | ||
| 12-1 Month Momentum % | 29.24 | ||
| 52-Week Range (â‚©) | 1424.7382 - 8670 | ||
| Shares Outstanding (Mil) | 46.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bridge Biotherapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bridge Biotherapeutics Inc Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bridge Biotherapeutics Inc Frequently Asked Questions
What is Bridge Biotherapeutics Inc(XKRX:288330)'s stock price today?
The current price of XKRX:288330 is â‚©7700.00. The 52 week high of XKRX:288330 is â‚©8670.00 and 52 week low is â‚©1424.74.
When is next earnings date of Bridge Biotherapeutics Inc(XKRX:288330)?
The next earnings date of Bridge Biotherapeutics Inc(XKRX:288330) is .
Does Bridge Biotherapeutics Inc(XKRX:288330) pay dividends? If so, how much?
Bridge Biotherapeutics Inc(XKRX:288330) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers